Skip to main content
Contact Us
Subscribe
E-Edition
36°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Names Seasoned Veteran as New EVP of Commercial Operations
September 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Reports on FDA Pre-IND Meeting to Advance Development of Lead Program
September 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
SILO
Viridian Therapeutics Discloses 'Exciting' Data From Experimental Thyroid Eye Disease Candidate, Says Data Met High Bars For Efficacy, Safety
September 10, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
VRDN
Purisys Activates Drug Master File for Nalmefene, Introducing New Solution for Acute Opioid Overdose Treatment
September 10, 2024
Via
Newsfile
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
September 04, 2024
Via
PRLog
Exposures
Product Safety
NRx Pharmaceuticals NRXP: Prominently Featured in Psychiatrist.com; Article Titled "How NRx Could Upend the Fight Against Depression and Suicide"
September 11, 2024
Via
PRLog
Exposures
Product Safety
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
September 10, 2024
Via
Benzinga
Exposures
Product Safety
Syntekabio Appoints Joonhyuk Choi, Former Target Health CEO, as Head of US Operations
September 10, 2024
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Volkswagen Recalls Every ID.4 SUV in U.S. for Door Malfunction Concerns
September 10, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
VLKAF
VWAGY
VWAPY
Building a Sustainable Future in Tech: Insights from Dominic Tria
September 10, 2024
Via
Zexprwire
Topics
Product Recall
Exposures
Legal
Product Safety
The Importance of Trust in Toronto’s Real Estate Market with Michelle Kam
September 10, 2024
Via
Zexprwire
Topics
Product Recall
Exposures
Legal
Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data Demonstrating TNX-801’s Single-Dose Immune Protection Against Mpox
September 09, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
Stellantis Recalls 1.46M Vehicles Globally Over Safety Software Flaw: Details
September 09, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment
September 09, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
RZLT
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?
September 09, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
INBS
Top Realtor Agent in Prescott, AZ, Reflects on Memorable Business Mistakes and Lessons Learned
September 09, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
FDA Rejection Of MDMA Could Fuel Black Market Demand, Warns CEO Of Women's Psychedelic Platform SetSet
September 07, 2024
Via
Benzinga
Exposures
Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches Educational Campaign to Inspire Patients to Optimize Migraine Treatment Plans with Non-Oral Medication
September 06, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMRN
BMY
GSK
LLY
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
September 06, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
PFE
VOR
Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock
September 06, 2024
Via
MarketBeat
Exposures
Product Safety
Tickers
MRK
TRVI
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
September 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CMPS
Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR”
September 05, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
INBS
KAVL
MODD
PM
Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
September 05, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ABT
Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion
September 05, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
BAX
MDT
'Tofu-Like' Psychedelic Gets FDA Nod - Mindstate's AI-Designed Therapy To Begin Human Trials
September 05, 2024
Via
Benzinga
Exposures
Product Safety
SugarMD Recent Crises and Improvements Discussed Thoroughly
September 05, 2024
Via
Get News
Exposures
Product Safety
Alopecia areata is an autoimmune disease, not a cosmetic issue
September 05, 2024
Via
Brandpoint
Topics
Product Recall
Exposures
Legal
Product Safety
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
September 04, 2024
Via
Benzinga
Exposures
Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Developing Fast-Track-Designated Treatment for Fibromyalgia
September 04, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.